ArticleGynecologic oncology reports2024
A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy.
Rebecca Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it